pHR-UCOE-EF1a-Zim3-dCas9-P2A-mCherry Citations (3)
Originally described in: Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.Replogle JM, Bonnar JL, Pogson AN, Liem CR, Maier NK, Ding Y, Russell BJ, Wang X, Leng K, Guna A, Norman TM, Pak RA, Ramos DM, Ward ME, Gilbert LA, Kampmann M, Weissman JS, Jost M eLife. 2022 Dec 28;11:e81856. doi: 10.7554/eLife.81856. PubMed Journal
Articles Citing pHR-UCOE-EF1a-Zim3-dCas9-P2A-mCherry
| Articles |
|---|
Comprehensive transcription factor perturbations recapitulate fibroblast transcriptional states.
Southard KM, Ardy RC, Tang A, O'Sullivan DD, Metzner E, Guruvayurappan K, Norman TM.
Nat Genet. 2025 Aug 6. doi: 10.1038/s41588-025-02284-1.
PubMed
Associated Plasmids |
| Incomplete paralog compensation generates selective dependency on TRA2A in cancer. Lee AR, Tangiyan A, Singh I, Choi PS. PLoS Genet. 2025 May 14;21(5):e1011685. doi: 10.1371/journal.pgen.1011685. eCollection 2025 May. PubMed |
| Enhancer-targeting CRISPR screens at coronary artery disease loci suggest shared mechanisms of disease risk. Ramste M, Weldy C, Kundu S, Zhao Q, Li D, Brand K, Sharma D, Ramste A, Jagoda E, Ray J, Caceres RD, Galante J, Gschwind AR, Lahtinen N, Nguyen T, Amrute JM, Park CY, Kim JB, Kaikkonen MU, Stitziel NO, Steinmetz L, Kundaje A, Engreitz JM, Quertermous T. medRxiv [Preprint]. 2025 Sep 2:2025.08.28.25334684. doi: 10.1101/2025.08.28.25334684. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.